Pharma Tech Co. Targets Rival Over Tracking Device IP

Law360, New York (November 2, 2011, 4:22 PM EDT) -- Pharmaceutical technology company Fuisz Pharma LLC sued rival Theranos Inc. on Tuesday in Delaware federal court, alleging the biotech company violated a patent that helps medical professionals track patients' responses to treatments.

Fuisz Pharma's suit alleges that handheld devices manufactured by Theranos used to detect drug-induced changes to a patient's biomedical markers and communicate the results to medical personnel violate U.S. Patent No. 7,824,612. Fuisz Pharma seeks an injunction, damages, pre- and post-judgment interest, attorneys' fees and a trial by jury.

“Theranos' acts have causes and,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.